We are live on ! Find out more
TSS

Thomas Story & Son Portfolio holdings

AUM $283M
1-Year Est. Return 40%
This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+40%
3 Year Est. Return
+91.81%
5 Year Est. Return
+109.54%
10 Year Est. Return
+394.03%
AUM
$162M
AUM Growth
-$21.3M
Cap. Flow
-$26.5M
Cap. Flow %
-16.34%
Top 10 Hldgs %
45.97%
Holding
63
New
1
Increased
1
Reduced
23
Closed
7

Top Buys

Rank Stock Value
1
GNTX icon
Gentex
GNTX
+$1.55M
2
BWP
Boardwalk Pipeline Partners
BWP
+$232K

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$2.23M
2
PX
Praxair Inc
PX
+$2.08M
3
FAST icon
Fastenal
FAST
+$1.88M
4
CLR
CONTINENTAL RESOURCES INC.
CLR
+$1.83M
5
V icon
Visa
V
+$1.82M

Sector Composition

Rank Sector Weight
1 Industrials 17.78%
2 Energy 16.29%
3 Technology 12.44%
4 Healthcare 12.31%
5 Financials 11.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$621B
$9.29M 5.73%
88,808
– –
SLB icon
2
SLB Ltd
SLB
$73.7B
$9.2M 5.67%
78,037
-11,149
-13% -$1.15M
INTC icon
3
Intel
INTC
$467B
$9.18M 5.65%
296,919
-50,200
-14% -$1.38M
PG icon
4
Procter & Gamble
PG
$336B
$8.28M 5.1%
105,290
– –
V icon
5
Visa
V
$684B
$7.24M 4.46%
137,480
-34,800
-20% -$1.82M
CB
6
DELISTED
CHUBB CORPORATION
CB
$6.96M 4.29%
75,510
-100
-0.1% -$9.2K
ESRX
7
DELISTED
Express Scripts Holding Company
ESRX
$6.8M 4.19%
98,050
-8,500
-8% -$598K
ACN icon
8
Accenture
ACN
$101B
$6.35M 3.91%
78,525
-14,000
-15% -$1.12M
XOM icon
9
ExxonMobil
XOM
$644B
$5.77M 3.56%
57,300
-8,045
-12% -$812K
ORLY icon
10
O'Reilly Automotive
ORLY
$72.8B
$5.54M 3.41%
551,475
-159,750
-22% -$1.58M
MMM icon
11
3M
MMM
$90.9B
$5.51M 3.39%
45,986
– –
ITW icon
12
Illinois Tool Works
ITW
$82.6B
$5.28M 3.25%
60,280
-200
-0.3% -$17.2K
SU icon
13
Suncor Energy
SU
$79.3B
$5.27M 3.25%
123,694
-28,850
-19% -$1.12M
FAST icon
14
Fastenal
FAST
$54.4B
$5.08M 3.13%
410,696
-151,600
-27% -$1.88M
XEC
15
DELISTED
CIMAREX ENERGY CO
XEC
$4.96M 3.06%
34,553
-100
-0.3% -$12.7K
MON
16
DELISTED
Monsanto Co
MON
$4.6M 2.83%
36,880
-5,850
-14% -$685K
TSCO icon
17
Tractor Supply
TSCO
$16.1B
$3.89M 2.4%
322,025
-59,500
-16% -$780K
KO icon
18
Coca-Cola
KO
$378B
$3.75M 2.31%
88,402
– –
SRCL
19
DELISTED
Stericycle Inc
SRCL
$3.71M 2.29%
31,344
-7,150
-19% -$818K
GNTX icon
20
Gentex
GNTX
$5B
$3.46M 2.13%
237,560
+106,250
+81% +$1.55M
BWXT icon
21
BWX Technologies
BWXT
$15.5B
$3.41M 2.1%
146,986
-40,821
-22% -$969K
CHRW icon
22
C.H. Robinson
CHRW
$17.5B
$3.19M 1.97%
50,000
– –
VZ icon
23
Verizon
VZ
$195B
$3.02M 1.86%
61,647
– –
BDX icon
24
Becton Dickinson
BDX
$45.7B
$2.49M 1.54%
21,594
– –
BBBY
25
DELISTED
Bed Bath & Beyond Inc
BBBY
$2.27M 1.4%
39,545
-9,550
-19% -$596K
1
2 3

Similar funds

TC
TAGStone Capital Charlotte, North Carolina $283M AUM 14.51% 1-Year Est. Return
UFAC
Urban Financial Advisory Corp Chicago, Illinois $283M AUM 13.45% 1-Year Est. Return
DIP
Davis Investment Partners Charlotte, North Carolina $283M AUM 24.98% 1-Year Est. Return
DRD
Dennis R. Delaney $282M AUM 16.32% 1-Year Est. Return
BO
Bank OZK Little Rock, Arkansas $283M AUM 24.45% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
PAG
Powers Advisory Group Highland, Illinois $284M AUM 13.36% 1-Year Est. Return
CCM
Chaney Capital Management Lynnwood, Washington $284M AUM 15.54% 1-Year Est. Return

Thomas Story & Son's Q2 2014 Portfolio in Review

As of Q2 2014, Thomas Story & Son held 63 positions worth $162M, down 12% from $184M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Thomas Story & Son withdrew a net $26.5M in Q2 2014, closing 7 positions and reducing 23 holdings. Its most notable exit was Idexx Laboratories, an estimated $2.23M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Energy and Technology.

Against the trend, Thomas Story & Son opened a new position in Boardwalk Pipeline Partners worth $263K.

  • Thomas Story & Son's largest Q2 2014 buy was Boardwalk Pipeline Partners: 14,200 shares worth $263K.
  • Thomas Story & Son added most to Gentex in Q2 2014, an estimated $1.55M increase.
  • Thomas Story & Son's biggest Q2 2014 reduction was Praxair Inc, cutting an estimated $2.08M.
  • Thomas Story & Son fully exited Idexx Laboratories in Q2 2014, selling an estimated $2.23M.
  • Thomas Story & Son's ten largest holdings make up 46% of its $162M portfolio in Q2 2014.
  • Thomas Story & Son opened 1 new position and closed 7 in Q2 2014.
  • Thomas Story & Son's portfolio value fell 12% quarter-over-quarter to $162M.

Based on Thomas Story & Son's 13F filing for Q2 2014, filed 1 Aug 2014.